Companies: 10,795·Total market cap: $144.5T
biote Corp.

biote Corp.

BTMDNASDAQHealthcare● Active
$2.34
+$0.00(+0.00%)
Market Cap$103211637
P/E Ratio
52W High$4.75
52W Low$1.27

biote Corp. (BTMD) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

btmd · stock forecast · 7 analysts (3M) · FMP · updated Jun 9, 2026

Analyst Rating & Consensus

Based on 7 Wall Street analysts in the past 3 months

SellBuy

Buy

7 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
6
Hold
1
Sell
0
Strong Sell
0
Total: 7 · Buy rate: 85.7%

12-Month Price Target

High

$4.00

Consensus

$3.25

+38.9% upside

Low

$2.50

Median: $3.25 · Last Close: $2.34

The biote Corp. (BTMD) analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month BTMD price target is $3.25, representing +38.9% upside from the current price of $2.34.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $3 (38.9%)

Consensus Target

$3.25

38.9% upside

High Target

$4

70.9%

Low Target

$2.5

6.8%

Current Price

$2.34

as of today

Based on analyst price targets, the BTMD stock price prediction for the next 12 months ranges from $2.5 to $4. The consensus BTMD price forecast of $3.25 implies 38.9% upside from the current price of $2.34.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-10$2.465.00%

1-day model range: $2.44–$2.47. Peak: $2.47 (+5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$2-31.4%
2028$1-42.2%
2029$1-46.7%
2030$1-48.8%
2031-49.8%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

79%0%21%
11Buy
0Neutral
3Sell
RSI (14)71.7Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · BTMD · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$2.26BUY
MA 10$2.14BUY
MA 20$2.09BUY
MA 50$1.99BUY
MA 100$1.98BUY
MA 200$2.42SELL
Current $BTMD · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$2.27BUY
EMA 10$2.19BUY
EMA 20$2.13BUY
EMA 50$2.06BUY
EMA 100$2.12BUY
EMA 200$2.49SELL
Current $BTMD · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Truist Securities2026-04-16
Maintains
BuyBuy
B. Riley Securities2026-03-12
Maintains
NeutralNeutral
TD Cowen2026-03-12
Maintains
BuyBuy
B. Riley Securities2025-08-07
Downgrade ↓
BuyNeutral
Craig-Hallum2025-03-13
Maintains
BuyBuy
Roth MKM2024-03-13
Maintains
BuyBuy
Roth MKM2024-01-18
Maintains
BuyBuy
Truist Securities2024-01-18
Maintains
BuyBuy
TD Cowen2023-08-15
Maintains
OutperformOutperform
Roth MKM2023-08-14
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on biote Corp. (BTMD) stock. Of the recent 14 rating actions, 0 were upgrades and 1 were downgrades. 7 analysts currently cover BTMD.

Analyst Recommendation Trends

Buy ratings211
Hold ratings00
Sell ratings00

BTMD analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$191M

↓ 11.7% YoY

Revenue Next Year

$204M

↑ 6.7% YoY

EPS This Year

$0.28

EPS Next Year

$0.36

↑ 28.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast BTMD EPS of $0.28 for the current fiscal year, based on estimates from 1 analysts. The BTMD revenue forecast is $191M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The BTMD stock forecast is supported by two independent data sources: analyst consensus ratings from 7 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BTMD price target is $3.25 (+38.9% upside), with an analyst consensus of Buy.

The BTMD short-term stock prediction for tomorrow is $2.46 (+5.00%). The BTMD stock price prediction for 2027 estimates an average of $2. The BTMD stock prediction for 2030 projects a range of $1–$1.

biote Corp. trades on NASDAQ under the ticker BTMD. The BTMD stock outlook for 2027 is broadly positive, supported by a Buy consensus among 86% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

BTMD forecast · 8 questions

According to 7 Wall Street analysts, the average 12-month BTMD price target is $3.25, with a high forecast of $4.00 and a low of $2.50. The median price target is shown in the chart above when available. This implies +38.9% potential upside from the current price of $2.34.

BTMD price targetWhat is BTMD price targetBTMD analyst price targetBTMD 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.